Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BDH. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.